Activity of fosfomycin alone or combined with cefoxitin in vitro and in vivo in a murine model of urinary tract infection due to Escherichia coli harbouring CTX-M-15-type extended-spectrum β-lactamase.

[1]  D. Livermore.  Current Epidemiology and Growing Resistance of Gram-Negative Pathogens , 2012, The Korean journal of internal medicine.

[2]  M. Falagas,et al.  Fosfomycin: evaluation of the published evidence on the emergence of antimicrobial resistance in Gram-negative pathogens. , 2012, The Journal of antimicrobial chemotherapy.

[3]  B. Fantin,et al.  Cefoxitin as an Alternative to Carbapenems in a Murine Model of Urinary Tract Infection Due to Escherichia coli Harboring CTX-M-15-Type Extended-Spectrum β-Lactamase , 2012, Antimicrobial Agents and Chemotherapy.

[4]  Thierry Naas,et al.  Global Spread of Carbapenemase-producing Enterobacteriaceae , 2011, Emerging infectious diseases.

[5]  M. Pfaller.  Kucers' The Use of Antibiotics Sixth Edition: A Clinical Review of Antibacterial, Antifungal and Antiviral Drugs , 2010 .

[6]  M. Kuskowski,et al.  Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  B. Fantin,et al.  Impact of Low-Level Resistance to Fluoroquinolones Due to qnrA1 and qnrS1 Genes or a gyrA Mutation on Ciprofloxacin Bactericidal Activity in a Murine Model of Escherichia coli Urinary Tract Infection , 2009, Antimicrobial Agents and Chemotherapy.

[8]  M. Falagas,et al.  Fosfomycin: use beyond urinary tract and gastrointestinal infections. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  Clinical,et al.  Performance Standards for Antimicrobial Susceptibility Testing; Eighteenth Informational Supplement , 2008 .

[10]  E. Denamur,et al.  Mutator phenotype confers advantage in Escherichia coli chronic urinary tract infection pathogenesis. , 2005, FEMS immunology and medical microbiology.

[11]  V. Lorian.  Antibiotics in laboratory medicine , 2005 .

[12]  D. Reeves.  Clinical Antimicrobial Assays , 1999 .

[13]  A. ...,et al.  The use of antibiotics : a clinical review of antibacterial, antifungal, and antiviral drugs , 1997 .

[14]  R. Pearson,et al.  Method of reliable determination of minimal lethal antibiotic concentrations , 1980, Antimicrobial Agents and Chemotherapy.